AZB & Partners and Cleary Gottlieb Steen & Hamilton have advised GlaxoSmithKline (GSK) on the $3.4 billion sale of its entire stake in India’s Hindustan Unilever, with Latham & Watkins representing the placement agents.

According to Reuters, this marks India’s largest secondary market block trade, and the tenth-largest globally. GSK, which owned a 5.7 percent stake in Hindustan Unilever is looking to split into two entities. 

The AZB team was led by partners Vinati Kastia, Daksh Trivedi, Ajay Bahl and Ankit Tandon.

A Latham & Watkins team led by partners Rajiv Gupta and Jiyeon Lee-Lim advised Morgan Stanley India Company, J.P. Morgan India and HSBC Securities and Capital Markets (India).

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com. 

Related Articles

Deals

AZB, STB act on OYO’s $525 mln U.S. bet

by Nimitt Dixit |

AZB & Partners has acted for Oravel Stays, the parent of e-hotelier OYO, on its proposed $525 million acquisition of U.S. motel operator G6 Hospitality from PE fund Blackstone. Simpson Thacher & Bartlett acted for Blackstone on the deal.

Deals

Nishimura advises Panasonic Connect on $1 bln partnership with Orix

by Asian Legal Business《亚洲法律杂志》 |

Nishimura & Asahi has advised Panasonic Connect, a subsidiary of Japan’s Panasonic Holdings, on a strategic capital partnership with ORIX for its projector business.

Features

BRIEFS: Pharma Provides Japan M&A Shot in the Arm as Drugmakers Hunt for Growth

by Sarah Wong |

Shackled by a shrinking population and weak domestic demand, corporate Japan has been looking overseas for inorganic expansion as anaemic domestic fundamentals curtail growth prospects and investor confidence.